Article
New York-More drugs are in the pipeline that may have a positive impact on the treatment of patients with age-related macular degeneration (AMD). One that is providing good results is anecortave acetate (15 mg) for depot suspension, (Retaane, Alcon).
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.